dc.contributor.author
Rancan, Fiorenza
dc.contributor.author
Volkmann, Hildburg
dc.contributor.author
Giulbudagian, Michael
dc.contributor.author
Schumacher, Fabian
dc.contributor.author
Stanko, Jessica Isolde
dc.contributor.author
Kleuser, Burkhard
dc.contributor.author
Blume-Peytavi, Ulrike
dc.contributor.author
Calderón, Marcelo
dc.contributor.author
Vogt, Annika
dc.date.accessioned
2020-02-28T08:53:39Z
dc.date.available
2020-02-28T08:53:39Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/26770
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-26527
dc.description.abstract
Polyglycerol-based thermoresponsive nanogels (tNGs) have been shown to have excellent skin hydration properties and to be valuable delivery systems for sustained release of drugs into skin. In this study, we compared the skin penetration of tacrolimus formulated in tNGs with a commercial 0.1% tacrolimus ointment. The penetration of the drug was investigated in ex vivo abdominal and breast skin, while different methods for skin barrier disruption were investigated to improve skin permeability or simulate inflammatory conditions with compromised skin barrier. The amount of penetrated tacrolimus was measured in skin extracts by liquid chromatography tandem-mass spectrometry (LC-MS/MS), whereas the inflammatory markers IL-6 and IL-8 were detected by enzyme-linked immunosorbent assay (ELISA). Higher amounts of tacrolimus penetrated in breast as compared to abdominal skin or in barrier-disrupted as compared to intact skin, confirming that the stratum corneum is the main barrier for tacrolimus skin penetration. The anti-proliferative effect of the penetrated drug was measured in skin tissue/Jurkat cells co-cultures. Interestingly, tNGs exhibited similar anti-proliferative effects as the 0.1% tacrolimus ointment. We conclude that polyglycerol-based nanogels represent an interesting alternative to paraffin-based formulations for the treatment of inflammatory skin conditions.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
tacrolimus formulation
en
dc.subject
skin penetration
en
dc.subject
drug delivery
en
dc.subject
human excised skin
en
dc.subject
Jurkat cells
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Dermal Delivery of the High-Molecular-Weight Drug Tacrolimus by Means of Polyglycerol-Based Nanogels
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
394
dcterms.bibliographicCitation.doi
10.3390/pharmaceutics11080394
dcterms.bibliographicCitation.journaltitle
Pharmaceutics
dcterms.bibliographicCitation.number
8
dcterms.bibliographicCitation.originalpublishername
MDPI AG
dcterms.bibliographicCitation.volume
11
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
31387279
dcterms.isPartOf.eissn
1999-4923